Login / Signup

Tolvaptan Versus Fluid Restriction in the Treatment of Hyponatremia Resulting from SIADH Following Pituitary Surgery.

Andrea KleindienstSimeon GeorgievSven Martin SchlafferMichael Buchfelder
Published in: Journal of the Endocrine Society (2020)
Tolvaptan at a moderate dose is more effective than fluid restriction in the treatment of SIADH. Overcorrection of serum sodium may be a side effect of tolvaptan even at low doses.
Keyphrases
  • acute heart failure
  • minimally invasive
  • heart failure
  • polycystic kidney disease
  • acute coronary syndrome
  • replacement therapy
  • percutaneous coronary intervention
  • surgical site infection